|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
3 May 2021 |
|
Main ID: |
NCT02907879 |
|
Date of registration:
|
16/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH
|
|
Scientific title:
|
Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After Subarachnoid Hemorrhage |
|
Date of first enrolment:
|
July 2013 |
|
Target sample size:
|
54 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT02907879 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Jürgen Beck, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospital Inselspital, Berne |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Proven SAH (CT or lumbar puncture)
- Proven aneurysm (digital subtraction angiography or CT-angiography)
- Age >18
- Informed consent of patient or relative
Exclusion Criteria:
- Pregnancy and breast feeding
- Acute coronary syndromes, severe ischemic heart disease (requiring revascularisation),
severe aortic and mitral valve disease, severe congestive heart failure (NYHA >III/IV)
- Severe pulmonary or renal dysfunction
- Known allergy or adverse reaction to contrast material
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Subarachnoid Hemorrhage
|
|
Primary Outcome(s)
|
|
Detection of cerebral hypoperfusion leading to either infarcts, neurological deficits, or initiation of rescue therapy
[Time Frame: 14 days after ictus]
|
|
Secondary Outcome(s)
|
|
Correlation between UPI parameters with vessel diameters of the MCA as assessed by DSA
[Time Frame: Within 14 days after ictus]
|
|
Correlation between UPI parameters and flow velocities in the middle cerebral artery as measured by TCD
[Time Frame: Within 14 days after ictus]
|
|
Correlation between UPI parameters and cerebral perfusion as assessed by MRI-perfusion
[Time Frame: Within 14 days after ictus]
|
|
Correlation between UPI parameters and cerebral perfusion as assessed by CT-perfusion
[Time Frame: Within 14 days after ictus]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|